Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis.

MLA

Inno, Alessandro, et al. “Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis.” Current Oncology Reports, vol. 25, no. 7, July 2023, pp. 743–51. EBSCOhost, https://doi.org/10.1007/s11912-023-01411-7.

APA

Inno, A., Tarantini, L., Parrini, I., Spallarossa, P., Maurea, N., Bisceglia, I., Silvestris, N., Russo, A., & Gori, S. (2023). Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis. Current Oncology Reports, 25(7), 743–751. https://doi.org/10.1007/s11912-023-01411-7

Chicago

Inno, Alessandro, Luigi Tarantini, Iris Parrini, Paolo Spallarossa, Nicola Maurea, Irma Bisceglia, Nicola Silvestris, Antonio Russo, and Stefania Gori. 2023. “Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis.” Current Oncology Reports 25 (7): 743–51. doi:10.1007/s11912-023-01411-7.